MarketBeat Instant News Alerts 2 hours agoEupraxia Pharmaceuticals (NASDAQ:EPRX) Coverage Initiated at WedbushMarketBeatWedbush began coverage on shares of Eupraxia Pharmaceuticals in a report on Thursday. They set an "outperform" rating and a $17.00 target price for the company.NASDAQ:EPRXRead Eupraxia Pharmaceuticals (NASDAQ:EPRX) Coverage Initiated at Wedbush2 hours agoScotiabank Cuts W.P. Carey (NYSE:WPC) Price Target to $68.00MarketBeatScotiabank reduced their target price on W.P. Carey from $76.00 to $68.00 and set a "sector perform" rating for the company in a research note on Thursday.NYSE:WPCRead Scotiabank Cuts W.P. Carey (NYSE:WPC) Price Target to $68.002 hours agoScotiabank Lowers NETSTREIT (NYSE:NTST) Price Target to $20.00MarketBeatScotiabank lowered their price objective on NETSTREIT from $22.00 to $20.00 and set a "sector outperform" rating for the company in a research report on Thursday.NYSE:NTSTRead Scotiabank Lowers NETSTREIT (NYSE:NTST) Price Target to $20.002 hours agoEssential Properties Realty Trust (NYSE:EPRT) Given New $30.00 Price Target at ScotiabankMarketBeatScotiabank reduced their price objective on shares of Essential Properties Realty Trust from $33.00 to $30.00 and set a "sector outperform" rating for the company in a research note on Thursday.NYSE:EPRTRead Essential Properties Realty Trust (NYSE:EPRT) Given New $30.00 Price Target at Scotiabank2 hours agoEverpure (NYSE:P) Price Target Raised to $145.00 at Wells Fargo & CompanyMarketBeatWells Fargo & Company boosted their price objective on shares of Everpure from $135.00 to $145.00 and gave the company an "overweight" rating in a report on Thursday.NYSE:PRead Everpure (NYSE:P) Price Target Raised to $145.00 at Wells Fargo & Company2 hours agoWells Fargo & Company Boosts Okta (NASDAQ:OKTA) Price Target to $230.00MarketBeatWells Fargo & Company lifted their target price on Okta from $200.00 to $230.00 and gave the stock an "overweight" rating in a report on Thursday.NASDAQ:OKTARead Wells Fargo & Company Boosts Okta (NASDAQ:OKTA) Price Target to $230.00 Trending News1Equities Analysts Issue Forecasts for Intel FY2027 Earnings2Christopher Cox Sells 40,000 Shares of Meta Platforms (NASDAQ:META) Stock3Boeing (NYSE:BA) Shares Down 1.6% Following Analyst Downgrade4Intuit (NASDAQ:INTU) Shares Down 4.5% - What's Next?5Oracle (NYSE:ORCL) CEO Sells 22,562 Shares6Jersey Mike's (NYSE:JMKE) Stock Price Down 4.2% - Here's Why7Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (NASDAQ:XNDU) Shares Gap Up - Should You Buy?8Intel (NASDAQ:INTC) Stock Price Up 1.7% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoCVS Group plc (LON:CVSG) Receives Average Rating of "Moderate Buy" from BrokeragesMarketBeatLON:CVSGRead CVS Group plc (LON:CVSG) Receives Average Rating of "Moderate Buy" from Brokerages2 hours agoAC Immune (NASDAQ:ACIU) Earns Buy Rating from BTIG ResearchMarketBeatNASDAQ:ACIURead AC Immune (NASDAQ:ACIU) Earns Buy Rating from BTIG Research2 hours agoTheravance Biopharma (NASDAQ:TBPH) Receives Neutral Rating from BTIG ResearchMarketBeatNASDAQ:TBPHRead Theravance Biopharma (NASDAQ:TBPH) Receives Neutral Rating from BTIG Research2 hours agoPraxis Precision Medicines (NASDAQ:PRAX) Earns "Buy" Rating from Needham & Company LLCMarketBeatNASDAQ:PRAXRead Praxis Precision Medicines (NASDAQ:PRAX) Earns "Buy" Rating from Needham & Company LLC2 hours agoBTIG Research Issues Pessimistic Forecast for McDonald's (NYSE:MCD) Stock PriceMarketBeatNYSE:MCDRead BTIG Research Issues Pessimistic Forecast for McDonald's (NYSE:MCD) Stock Price2 hours agoBooking (NASDAQ:BKNG) Given Buy Rating at BTIG ResearchMarketBeatNASDAQ:BKNGRead Booking (NASDAQ:BKNG) Given Buy Rating at BTIG Research2 hours agoAmericas Gold and Silver (NYSEAMERICAN:USAS) Given Buy Rating at HC WainwrightMarketBeatNYSEAMERICAN:USASRead Americas Gold and Silver (NYSEAMERICAN:USAS) Given Buy Rating at HC Wainwright2 hours agoTyler Technologies (NYSE:TYL) Earns Buy Rating from BTIG ResearchMarketBeatNYSE:TYLRead Tyler Technologies (NYSE:TYL) Earns Buy Rating from BTIG Research2 hours agoBank of America Initiates Coverage on MGE Energy (NASDAQ:MGEE)MarketBeatNASDAQ:MGEERead Bank of America Initiates Coverage on MGE Energy (NASDAQ:MGEE)2 hours agoDycom Industries (NYSE:DY) Given "Overweight" Rating at Cantor FitzgeraldMarketBeatNYSE:DYRead Dycom Industries (NYSE:DY) Given "Overweight" Rating at Cantor Fitzgerald2 hours agoEverpure (NYSE:P) Price Target Raised to $150.00 at Needham & Company LLCMarketBeatNYSE:PRead Everpure (NYSE:P) Price Target Raised to $150.00 at Needham & Company LLC2 hours agoAlmonty Industries (NASDAQ:ALM) Earns Neutral Rating from Analysts at The Goldman Sachs GroupMarketBeatNASDAQ:ALMRead Almonty Industries (NASDAQ:ALM) Earns Neutral Rating from Analysts at The Goldman Sachs Group2 hours agoSanford C. Bernstein Reaffirms Outperform Rating for Fervo Energy (NASDAQ:FRVO)MarketBeatNASDAQ:FRVORead Sanford C. Bernstein Reaffirms Outperform Rating for Fervo Energy (NASDAQ:FRVO)2 hours agoAurora Innovation (NASDAQ:AUR) Given Buy Rating at Needham & Company LLCMarketBeatNASDAQ:AURRead Aurora Innovation (NASDAQ:AUR) Given Buy Rating at Needham & Company LLC2 hours agoIonis Pharmaceuticals (NASDAQ:IONS) Receives "Buy" Rating from HC WainwrightMarketBeatNASDAQ:IONSRead Ionis Pharmaceuticals (NASDAQ:IONS) Receives "Buy" Rating from HC Wainwright2 hours agoNeoVolta's (NEOV) "Buy" Rating Reaffirmed at Needham & Company LLCMarketBeatNASDAQ:NEOVRead NeoVolta's (NEOV) "Buy" Rating Reaffirmed at Needham & Company LLC2 hours agoMaze Therapeutics (NASDAQ:MAZE) Receives Buy Rating from HC WainwrightMarketBeatNASDAQ:MAZERead Maze Therapeutics (NASDAQ:MAZE) Receives Buy Rating from HC Wainwright2 hours agoHC Wainwright Reaffirms "Buy" Rating for Oruka Therapeutics (NASDAQ:ORKA)MarketBeatNASDAQ:ORKARead HC Wainwright Reaffirms "Buy" Rating for Oruka Therapeutics (NASDAQ:ORKA)2 hours agoCoreWeave (NASDAQ:CRWV) Stock Rating Upgraded by JPMorgan Chase & Co.MarketBeatNASDAQ:CRWVRead CoreWeave (NASDAQ:CRWV) Stock Rating Upgraded by JPMorgan Chase & Co.2 hours agoMicron Technology (NASDAQ:MU) Given Buy Rating at Rosenblatt SecuritiesMarketBeatNASDAQ:MURead Micron Technology (NASDAQ:MU) Given Buy Rating at Rosenblatt Securities2 hours agoThe Goldman Sachs Group Reaffirms Neutral Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)MarketBeatNASDAQ:ARWRRead The Goldman Sachs Group Reaffirms Neutral Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)2 hours agoDarden Restaurants' (DRI) Hold Rating Reiterated at TD CowenMarketBeatNYSE:DRIRead Darden Restaurants' (DRI) Hold Rating Reiterated at TD Cowen2 hours agoYum! Brands (NYSE:YUM) Given "Hold" Rating at ArgusMarketBeatNYSE:YUMRead Yum! Brands (NYSE:YUM) Given "Hold" Rating at Argus2 hours agoThe Goldman Sachs Group Reaffirms "Neutral" Rating for AbCellera Biologics (NASDAQ:ABCL)MarketBeatNASDAQ:ABCLRead The Goldman Sachs Group Reaffirms "Neutral" Rating for AbCellera Biologics (NASDAQ:ABCL) Featured Articles and OffersNVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In ItBy Bridget Bennett | September 20, 2026While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!From Trading Wire (Ad)The Fed’s Rate Hike Could Backfire If Oil Prices CollapseBy Thomas Hughes | September 17, 2026Aeluma’s Selloff Could Be Setting Up Its Next Big MoveBy Thomas Hughes | September 17, 2026The AI Bottleneck Is Not Chips Anymore and 3 Pipeline Stocks Are Cashing InBy Bridget Bennett | September 20, 2026While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!From Trading Wire (Ad)Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?By Thomas Hughes | September 21, 2026Braze Beat Expectations—Now 2 SaaS Peers Are in FocusBy Nathan Reiff | September 18, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 199 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
